Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Conditions

Venous Thromboembolism 5 Neoplasms 5 Treatment of Venous Thromboembolism in Cancer Patients 3 Pulmonary Embolism 2 Venous Thrombosis 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Thrombosis 1 Ovarian Neoplasms 1 Myeloproliferative Disorders 1 Endometrial Neoplasms 1 Embolism 1

Interventions

calcium heparin 1 Tinzaparin 1 Rivaroxaban 1 Laparoscopy 1 Heparin 1 Fondaparinux 1 Enoxaparin 1 Data Collection 1 Dalteparin 1 Conversion to Open Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Venous Thrombosis × Rivaroxaban × Clear all

NCT02742623 2023-11-07

COSIMO

Bayer

Neoplasms, Pulmonary Embolism, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡